MediWound Ltd.
MDWD
$16.29
-$0.06-0.37%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 18.69M | 24.97M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 18.69M | 24.97M | |
| Cost of Revenue | -- | -- | 15.11M | 13.95M | |
| Gross Profit | -- | -- | 3.58M | 11.02M | |
| SG&A Expenses | -- | -- | 11.61M | 11.78M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | 0.00 | -224.00K | |
| Total Operating Expenses | -- | -- | 34.19M | 33.66M | |
| Operating Income | -- | -- | -15.50M | -8.69M | |
| Income Before Tax | -- | -- | -6.53M | -12.30M | |
| Income Tax Expenses | -- | -- | 185.00K | 130.00K | |
| Earnings from Continuing Operations | -- | -- | -6.72 | -12.43 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -6.72M | -12.43M | |
| EBIT | -- | -- | -15.50M | -8.69M | |
| EBITDA | -- | -- | -14.36M | -7.55M | |
| EPS Basic | -- | -- | -0.77 | -1.76 | |
| Normalized Basic EPS | -- | -- | -0.62 | -0.57 | |
| EPS Diluted | -- | -- | -0.77 | -1.76 | |
| Normalized Diluted EPS | -- | -- | -0.62 | -0.57 | |
| Average Basic Shares Outstanding | -- | -- | 36.03M | 33.15M | |
| Average Diluted Shares Outstanding | -- | -- | 36.03M | 33.15M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |